Pharmaceutical Technology1 天
COVID-19 (S Protein) by Vaxart for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
COVID-19 (S Protein) is under clinical development by Vaxart and currently in Phase II for Coronavirus Disease 2019 (COVID-19).
Pharmaceutical Technology2 天
NG-350a by Akamis Bio for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
NG-350a is under clinical development by Akamis Bio and currently in Phase I for Metastatic Adenocarcinoma of The Pancreas.